2020
DOI: 10.3917/polaf.156.0041
|View full text |Cite
|
Sign up to set email alerts
|

Produire des médicaments en Afrique subsaharienne à l’heure de la santé globale. Le cas des antipaludiques au Ghana

Abstract: Le paludisme constitue un problème majeur de santé publique au Ghana, qui dépend du soutien des programmes de santé globale pour la distribution des traitements. Ils conditionnent leurs financements à l’achat de médicaments à la qualité certifiée par l’Organisation mondiale de la santé, label dont les firmes ghanéennes ne bénéficient pas faute de moyens, les laissant en marge des marchés. Le Ghana, avec le soutien d’autres partenaires, tente néanmoins de mettre en œuvre une politique de soutien à la production… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
1
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

1
3

Authors

Journals

citations
Cited by 4 publications
(2 citation statements)
references
References 11 publications
0
1
0
Order By: Relevance
“…Donor-funded procurement schemes required medicine manufacturers to have quality certifications, most often the World Health Organization prequalification set up in 2001 in the context of conflicts over intellectual property and increasing measures against counterfeit drugs led by multinational pharmaceutical industries with international organisations (Quet 2021). Although some donors, such as the Global Fund to fight HIV/AIDS, Malaria and Tuberculosis did not exclude local producers from its tenders and created schemes to support local manufacturers, in practice, the quality requirements and procurement in bulk constituted barriers for local medicine manufacturers (Pourraz 2019;Chorev 2020). Investing in the upgrade of their infrastructure and procedures to comply with the quality standards reflected on their production costs and consequently affected their competitiveness, even in those countries with industrial policies to support local industries.…”
Section: Voicing the Economic Viability Logicmentioning
confidence: 99%
“…Donor-funded procurement schemes required medicine manufacturers to have quality certifications, most often the World Health Organization prequalification set up in 2001 in the context of conflicts over intellectual property and increasing measures against counterfeit drugs led by multinational pharmaceutical industries with international organisations (Quet 2021). Although some donors, such as the Global Fund to fight HIV/AIDS, Malaria and Tuberculosis did not exclude local producers from its tenders and created schemes to support local manufacturers, in practice, the quality requirements and procurement in bulk constituted barriers for local medicine manufacturers (Pourraz 2019;Chorev 2020). Investing in the upgrade of their infrastructure and procedures to comply with the quality standards reflected on their production costs and consequently affected their competitiveness, even in those countries with industrial policies to support local industries.…”
Section: Voicing the Economic Viability Logicmentioning
confidence: 99%
“…The pharmaceutical industry is one of the most vibrant sectors of the Ghanaian economy (Harper and Gyansa-Lutterodt, 2007;Otoo, 2020;Pourraz, 2019). The industry is highly competitive due to customer expectations and their enormous economic influence (Banda et al, 2021;Boya and Rao Sekhara, 2019;Horner, 2022).…”
Section: Introductionmentioning
confidence: 99%